BioCryst Pharmaceuticals Inc BCRX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:27 PM EST
12.26quote price arrow down-0.38 (-3.01%)
Volume
133,416
Close
12.64quote price arrow up+0.38 (+3.10%)
Volume
1,948,477
52 week range
7.61 - 19.99
Loading...
  • Open12.28
  • Day High12.65
  • Day Low12.15
  • Prev Close12.26
  • 52 Week High19.99
  • 52 Week High Date02/16/22
  • 52 Week Low7.61
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap2.356B
  • Shares Out186.42M
  • 10 Day Average Volume1.93M
  • Dividend-
  • Dividend Yield-
  • Beta1.97
  • YTD % Change-8.74

KEY STATS

  • Open12.28
  • Day High12.65
  • Day Low12.15
  • Prev Close12.26
  • 52 Week High19.99
  • 52 Week High Date02/16/22
  • 52 Week Low7.61
  • 52 Week Low Date05/12/22
  • Market Cap2.356B
  • Shares Out186.42M
  • 10 Day Average Volume1.93M
  • Dividend-
  • Dividend Yield-
  • Beta1.97
  • YTD % Change-8.74

RATIOS/PROFITABILITY

  • EPS (TTM)-1.04
  • P/E (TTM)-12.10
  • Fwd P/E (NTM)-11.26
  • EBITDA (TTM)-153.089M
  • ROE (TTM)-1,925.37%
  • Revenue (TTM)238.44M
  • Gross Margin (TTM)98.11%
  • Net Margin (TTM)-81.09%
  • Debt To Equity (MRQ)-294.10%

EVENTS

  • Earnings Date02/21/2023(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On BioCryst Pharmaceuticals Inc

 

Profile

MORE
BioCryst Pharmaceuticals, Inc. discovers oral and small-molecule medicines that treat rare diseases in which unmet medical needs exist and an enzyme plays the key role in the biological pathway of the disease. ORLADEYO (berotralstat) is an oral, once-daily therapy that is approved in the United States, the European Union, Japan, and the United Kingdom for the prevention of hereditary angioedema attacks in adults and pediatric patients 12 years and older. The Company has...
Robert Ingram
Independent Chairman of the Board
Jon Stonehouse
President, Chief Executive Officer, Director
Anthony Doyle
Chief Financial Officer
Address
4505 Emperor Blvd Ste 200
Durham, NC
27703-8457
United States

Top Peers

SYMBOLLASTCHG%CHG
INSM
Insmed Inc
18.11-0.38-2.06%
PACB
Pacific Biosciences of California Inc
9.45-0.27-2.78%
VCYT
Veracyte Inc
25.49+0.22+0.87%
RARE
Ultragenyx Pharmaceutical Inc
35.67+0.27+0.76%
ARVN
Arvinas Inc
38.29-0.69-1.77%